No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of no treatment compared
with ibuprofen treatment for patent ductus arteriosus in preterm infants. The study
hypothesis is that no treatment is not inferior to oral ibuprofen treatment in preterm
infants. (non-inferiority study)